PW–002Clinical Trial
Weight Loss
AOD-9604
Fat breakdown and body weight reduction
Main contextFat metabolism and weight
Goals
Weight Loss & Metabolic
4 peptides4 protocols
Peptides commonly researched for weight loss & metabolic applications.
Research Use Only: This information is for educational and research purposes only. Not intended for medical advice or self-medication.
Recommended Peptides
Peptides commonly researched for weight loss & metabolic applications.
PW–064Experimental
Weight Loss
SLU-PP-332
Switching on the metabolic pathways of aerobic exercise
Main contextMimicking aerobic exercise
PW–062Approved
Weight Loss
Semaglutide
Long-term blood sugar control and weight loss
Main contextDiabetes and weight loss
PW–072Approved
Weight Loss
Tirzepatide
Blood sugar control in diabetes and weight loss
Main contextBlood sugar and weight control
Peptide Comparison
Compare key properties of weight loss & metabolic peptides side by side.
Weight Loss & Metabolic Peptides
Compare 4 peptides commonly studied for weight loss & metabolic applications
| Typical Dose | |||||
|---|---|---|---|---|---|
| AOD-9604 | Clinical Trial | 🏋️Weight Loss | 1,815.08 Da | 400 mcg Daily morning fasted, 12-16 week cycles with 4-6 week breaks | |
| SLU-PP-332 | Experimental | 🏋️Weight Loss | 290.32 Da | — | |
| Semaglutide | Approved | 🏋️Weight Loss | 4,113.58 Da | 2.0 mg Once weekly; Ozempic: titrate from 0.25 mg to max 1 mg; Wegovy: up to 2.4 mg | |
| Tirzepatide | Approved | 🏋️Weight Loss | 4,813.45 Da | 10.0 mg Once weekly; titrate by 2500 mcg every 4 weeks |
Comparing 4 peptides
Related Protocols
Research protocols targeting weight loss & metabolic objectives.
AOD-9604 Fat Loss Stack
⚖️Weight LossIntermediate
Research peptide for targeted fat loss without affecting blood sugar. Can be stacked with other protocols.
Duration:20-30 days
Frequency:Once daily, preferably morning fasted or before cardio
1 peptide
AOD-9604
SLU-PP-332 — Metabolic Enhancement
⚖️Weight LossAdvanced
Experimental protocol based on the exercise mimetic SLU-PP-332 (ERRα/β/γ agonist) for enhancing fat oxidation, increasing endurance, and improving metabolic profile. For preclinical research only.
Duration:28 days (protocol per Billon et al., 2024)
Frequency:Twice daily, intraperitoneally (in preclinical models)
1 peptide
SLU-PP-332
Semaglutide Weight Loss - Beginner
⚖️Weight LossBeginner
FDA-approved GLP-1 protocol for safe, effective weight loss. Ideal for first-time users.
Duration:Long-term therapy (6+ months)
Frequency:Once weekly subcutaneous injection
1 peptide
Semaglutide
Tirzepatide Advanced Weight Loss
⚖️Weight LossAdvanced
Superior dual GLP-1/GIP agonist for maximum weight loss. Achieves 4-12 lbs more loss than Semaglutide.
Duration:Long-term therapy (6+ months)
Frequency:Once weekly subcutaneous injection
1 peptide
Tirzepatide
Need Help with Dosages?
Use our dosage calculator to determine reconstitution volumes, injection amounts, and how many doses you can get from each vial for any peptide.